STK17B
Serine/threonine-protein kinase 17B
Also known as: DRAK2, ST17B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O94768
- Gene
- STK17B
- Ensembl
- ENSG00000081320
- Chromosome
- 2
- Canonical length
- 372 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables ATP binding activity and protein serine/threonine kinase activity. Involved in intracellular signal transduction; positive regulation of fibroblast apoptotic process; and protein phosphorylation. Located in Flemming body and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
372 residues, UniProt reviewed canonical sequence.
>O94768|STK17B
1 MSRRRFDCRS ISGLLTTTPQ IPIKMENFNN FYILTSKELG RGKFAVVRQC ISKSTGQEYA
61 AKFLKKRRRG QDCRAEILHE IAVLELAKSC PRVINLHEVY ENTSEIILIL EYAAGGEIFS
121 LCLPELAEMV SENDVIRLIK QILEGVYYLH QNNIVHLDLK PQNILLSSIY PLGDIKIVDF
181 GMSRKIGHAC ELREIMGTPE YLAPEILNYD PITTATDMWN IGIIAYMLLT HTSPFVGEDN
241 QETYLNISQV NVDYSEETFS SVSQLATDFI QSLLVKNPEK RPTAEICLSH SWLQQWDFEN
301 LFHPEETSSS SQTQDHSVRS SEDKTSKSSC NGTCGDREDK ENIPEDSSMV SKRFRFDDSL
361 PNPHELVSDL LCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STK17B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 356 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 356 nTPM
- lymph node: 106 nTPM
- tonsil: 104 nTPM
- appendix: 63 nTPM
- thymus: 57 nTPM
- spleen: 54 nTPM
Single-cell type
- neutrophils: 3,217 nCPM
- neutrophil progenitors: 1,112 nCPM
- t-cells: 869 nCPM
- mast cells: 790 nCPM
- monocytes: 784 nCPM
- cdc: 762 nCPM
Immune cell
- neutrophil: 238 nTPM
- basophil: 166 nTPM
- eosinophil: 163 nTPM
- non-classical monocyte: 113 nTPM
- naive CD4 T-cell: 99 nTPM
- total PBMC: 89 nTPM
Brain region
- cerebral cortex: 16 nTPM
- thalamus: 14 nTPM
- hippocampal formation: 14 nTPM
- cerebellum: 13 nTPM
- choroid plexus: 12 nTPM
- hypothalamus: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.58
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- intracellular signal transduction
- positive regulation of apoptotic process
- positive regulation of fibroblast apoptotic process
- protein autophosphorylation
- protein phosphorylation
Molecular functions
- ATP binding
- protein kinase activity
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Protein kinase, ATP binding site
- Protein kinase domain
- Serine/threonine-protein kinase 17B, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STK17B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STK17B as an antibody target. Whether an autoantibody or antibody against STK17B could matter depends on whether native STK17B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STK17B is annotated at the cell surface, where native STK17B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label STK17B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...